ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 103 filers reported holding ALLAKOS INC in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,963 | +174.0% | 10,116 | +426.3% | 0.00% | – |
| Q2 2023 | $8,380 | -95.3% | 1,922 | -96.6% | 0.00% | – |
| Q2 2022 | $178,000 | +256.0% | 56,826 | +553.5% | 0.00% | – |
| Q1 2022 | $50,000 | -92.5% | 8,696 | -87.3% | 0.00% | -100.0% |
| Q4 2021 | $669,000 | -9.2% | 68,291 | +880.9% | 0.00% | 0.0% |
| Q3 2021 | $737,000 | -13.3% | 6,962 | -30.0% | 0.00% | 0.0% |
| Q2 2021 | $850,000 | -23.2% | 9,951 | +25.8% | 0.00% | -50.0% |
| Q4 2020 | $1,107,000 | +658.2% | 7,908 | +289.4% | 0.00% | +100.0% |
| Q2 2020 | $146,000 | -36.0% | 2,031 | -60.4% | 0.00% | -50.0% |
| Q1 2020 | $228,000 | -60.1% | 5,131 | -29.4% | 0.00% | -60.0% |
| Q3 2019 | $571,000 | – | 7,264 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
| NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
| Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
| Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
| Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
| Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
| Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
| RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
| Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |